Cellectis
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
Filings
8 filings
- Cellectis Reports Financial Results for the First Quarter 2026Quarterly financial informationFR
- Cellectis Reports Third Quarter 2025 Financial Results and Provides Business UpdateQuarterly financial informationFR
- Cellectis to Report Third Quarter Financial Results on November 7, 2025Quarterly financial informationFR
- Cellectis Reports Financial Results for the First Quarter 2025Quarterly financial informationFR
About
- ISIN
- FR0010425595
- Ticker
- ALCLS
- LEI
- 5493000KKX5VQ37Q2W83
- Sector
- Health care
- Founded
- 1999
- Country of registration
- FR
- Last filing
- 06/08/2026, 22:30
Description from Wikidata, CC0 licence.
Filing history
Filings per month
10
Sept 23May 24Jan 25Sept 25Aug 26
Document types
Across the whole archive